Advanced search
Publication Cover
Clinical Toxicology Volume 60, 2022 - Issue 11
Submit an article Journal homepage
246
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor: Original Scientific Contributions

Intravenous lipid emulsion for ivermectin toxicity in an eight-year-old male

Molly K. Stotta FL/USVI Poison Information Center, Jacksonville, FL, USACorrespondence[email protected]
,
Martha S. Phillipsb Baptist Medical Center, Wolfson Children’s Hospital, Jacksonville, FL, USA
&
Sophia Sheikhc Department of Emergency Medicine, University of Florida College of Medicine Jacksonville, FL/USVI Poison Information Center, Jacksonville, FL, USA
Pages 1287-1288 | Received 21 Jul 2022, Accepted 05 Oct 2022, Published online: 20 Oct 2022

References

  • Clarke DL, Lee JA, Murphy LA, et al. Use of intravenous lipid emulsion to treat ivermectin toxicosis in a border collie. J Am Vet Med Assoc. 2011;239(10):1328–1333.
  • Becker MD, Young BC. Treatment of severe lipophilic intoxications with intravenous lipid emulsion: a case series (2011–2014). Vet Med. 2017;8(8):77–85.
  • Kidwell JH, Buckley GJ, Allen AE, et al. Use of IV lipid emulsion for treatment of ivermectin toxicosis in a cat. J Am Anim Hosp Assoc. 2014;50(1):59–61.
  • Saqib M, Abbas G, Mughal MN. Successful management of ivermectin-induced blindness in an African lion (Panthera leo) by intravenous administration of a lipid emulsion. BMC Vet Res. 2015;11(11):287.
  • Elgazzar FM, Elgohary MS, Basiouny SM, et al. Intravenous lipid emulsion as an adjuvant therapy of acute clozapine poisoning. Hum Exp Toxicol. 2021;40(7):1053–1063.
  • Chandler RE. Serious neurological adverse events after ivermectin – do they occur beyond the indication of onchocerciasis? Am J Trop Med Hyg. 2018;98(2):382–388.
  • Farah R, Kazzi Z, Brent J, et al. Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project. Clin Toxicol. 2022;60(8):942–946.
  • National Center for Biotechnology Information. PubChem compound summary for CID 6321424, ivermectin [cited 2022 Aug 5]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Ivermectin

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.